Cargando…

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Currently, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly known as 2019-nCoV, the causative pathogen of Coronavirus Disease 2019 (COVID-19)) has rapidly spread across China and around the world, causing an outbreak of acute infectious pneumonia. No specific anti-virus drugs or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Islam, Md Sahidul, Wang, Jin, Li, Yuan, Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098036/ https://www.ncbi.nlm.nih.gov/pubmed/32226288 http://dx.doi.org/10.7150/ijbs.45538

Ejemplares similares

Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)
por: Ling, Chang-quan
Publicado: (2020)

2019_nCoV/SARS‐CoV‐2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses
por: Wassenaar, T.M., et al.
Publicado: (2020)

The role of traditional Chinese medicine in the prevention and treatment of coronavirus disease 2019
por: Yao, Chensi, et al.
Publicado: (2022)

Bibliometric analysis of researches on traditional Chinese medicine for coronavirus disease 2019 (COVID-19)
por: Yang, Ke-Lu, et al.
Publicado: (2020)

Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection
por: Li, Chang, et al.
Publicado: (2020)

The efficacy and safety of traditional Chinese medicines, modified Radix Fici Simplicissimae, combined with Western medicines amongst patients infected with the 2019 novel coronavirus (SARS-CoV-2) in tropical tourist area, China
por: Chen, Juan, et al.
Publicado: (2021)

The dynamics of patient visits to traditional Chinese medicine during the 2019 coronavirus pandemic
por: Lin, Shun-Ku, et al.
Publicado: (2021)

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020)

Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
por: Ashour, Hossam M., et al.
Publicado: (2020)

The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2
por: Zhu, James, et al.
Publicado: (2020)

Focus on a 2019-novel coronavirus (SARS-CoV-2)
por: Zhang, Ling-Pu, et al.
Publicado: (2020)

Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP)
por: DU, Hong-Zhi, et al.
Publicado: (2020)

State-of-the-art evidence of traditional Chinese medicine for treating coronavirus disease 2019
por: Liu, Jianping, et al.
Publicado: (2022)

An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2
por: Bahramsoltani, Roodabeh, et al.
Publicado: (2020)

Guidelines on the treatment with integrated traditional Chinese medicine and western medicine for severe coronavirus disease 2019
por: Li, Zhi-Yu, et al.
Publicado: (2021)

Analysis on application law of dampness-removing traditional Chinese medicines in treatment of coronavirus disease 2019
por: Hao, Er-wei, et al.
Publicado: (2021)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
por: Qiu, Qin, et al.
Publicado: (2020)

Traditional Chinese Medicine in Treating Children With Coronavirus Disease 2019: A Scoping Review
por: Duan, Naifan, et al.
Publicado: (2022)

Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2)
por: Vo, Van Giau, et al.
Publicado: (2020)

Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
por: Liu, Ping, et al.
Publicado: (2020)

Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2
por: Mirhosseini, Haniye, et al.
Publicado: (2023)

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
por: Du, Ashuai, et al.
Publicado: (2021)

Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
por: Xie, Mingxuan, et al.
Publicado: (2020)

The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good
por: Gray, Paul E., et al.
Publicado: (2020)

Could nanotechnology assist traditional Chinese medicine (TCM) in photodynamic therapy (PDT) against SARS-CoV-2?
por: Law, Siukan, et al.
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?
por: Li, Lin, et al.
Publicado: (2022)

Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV
por: Yang, Chu-Wen, et al.
Publicado: (2020)

Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis
por: Li, Zheng, et al.
Publicado: (2020)

Successful Intervention with Traditional Chinese Medicine for Severe Coronavirus Disease 2019: A Case Report
por: Lu, Wei, et al.
Publicado: (2022)

Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
por: Wang, Zhonglei, et al.
Publicado: (2021)

Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019
por: Cheong, Kai Xiong
Publicado: (2020)

Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019
por: Huang, Min, et al.
Publicado: (2020)

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
por: Xu, Xi, et al.
Publicado: (2020)

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
por: Wang, Lisheng, et al.
Publicado: (2020)

Correction: Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
por: Liu, Ping, et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ef782rfd6qelm85e124smq3vj